SCM
APLT

Sterling Capital Management’s Applied Therapeutics APLT Stock Holding History

Sterling Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-726
Closed -$355 – 3274
2025
Q1 		$355 Sell
726
-621
-46% -$366 ﹤0.01% 3014
2024
Q4 		$1.15K Buy
1,347
+1,167
+648% +$7.32K ﹤0.01% 2912
2024
Q3 		$1.53K Buy
+180
New +$1.06K ﹤0.01% 2319

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Sterling Capital Management's APLT Position: Q2 2025 in Review

Sterling Capital Management sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 726 shares — an estimated $355 sold.

Sterling Capital Management first reported a position in APLT in Q3 2024 and held it in 3 quarters. The position peaked at $1.53K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Sterling Capital Management reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 726 Applied Therapeutics shares in Q2 2025, an estimated $355.
  • Sterling Capital Management first reported a position in Applied Therapeutics in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Applied Therapeutics position peaked at $1.53K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.